357 related articles for article (PubMed ID: 17583829)
1. [Cerebrotendinous xanthomatosis].
Burghaus L; Liu W; Haupt WF
Dtsch Med Wochenschr; 2007 Jul; 132(27):1463-6. PubMed ID: 17583829
[TBL] [Abstract][Full Text] [Related]
2. Normalisation of serum cholestanol concentration in a patient with cerebrotendinous xanthomatosis by combined treatment with chenodeoxycholic acid, simvastatin and LDL apheresis.
Dotti MT; Lütjohann D; von Bergmann K; Federico A
Neurol Sci; 2004 Oct; 25(4):185-91. PubMed ID: 15549503
[TBL] [Abstract][Full Text] [Related]
3. Cerebrotendinous xanthomatosis in three siblings from a Chinese family.
Ko KF; Lee KW
Singapore Med J; 2001 Jan; 42(1):30-2. PubMed ID: 11361235
[TBL] [Abstract][Full Text] [Related]
4. Cerebrotendinous xanthomatosis.
Bel S; García-Patos V; Rodríguez L; Selva A; Díaz P; Wolthers BG; Castells A
J Am Acad Dermatol; 2001 Aug; 45(2):292-5. PubMed ID: 11464194
[TBL] [Abstract][Full Text] [Related]
5. Chronic diarrhea and juvenile cataracts: think cerebrotendinous xanthomatosis and treat.
Berginer VM; Gross B; Morad K; Kfir N; Morkos S; Aaref S; Falik-Zaccai TC
Pediatrics; 2009 Jan; 123(1):143-7. PubMed ID: 19117873
[TBL] [Abstract][Full Text] [Related]
6. Cerebrotendinous xanthomatosis: a treatable cause of metabolic ataxia.
Mukherjee AA; Chawla BP; Rathi SS; Puthran RS
J Assoc Physicians India; 2007 Sep; 55():655-7. PubMed ID: 18051740
[TBL] [Abstract][Full Text] [Related]
7. Cerebrotendinous xanthomatosis: a treatable ataxia.
Clemen CS; Spottke EA; Lütjohann D; Urbach H; von Bergmann K; Klockgether T; Dodel R
Neurology; 2005 Apr; 64(8):1476. PubMed ID: 15851751
[No Abstract] [Full Text] [Related]
8. [Laboratory diagnosis of a rare congenital neurodegenerative disease: cerebrotendinous xanthomatosis].
Varga VE; Katkó M; Harangi J; Balogh I; Kapás I; Madar L; Seres I; Molnár MJ; Paragh G; Kovács GG; Harangi M
Orv Hetil; 2014 May; 155(21):811-6. PubMed ID: 24836315
[TBL] [Abstract][Full Text] [Related]
9. [Cerebrotendinous xanthomatosis].
Verrips A
Ned Tijdschr Geneeskd; 2001 Sep; 145(35):1673-7. PubMed ID: 11561482
[TBL] [Abstract][Full Text] [Related]
10. Could steroids mask the diagnosis of cerebrotendinous xanthomatosis?
Siman-Tov T; Meiner V; Gadoth N
J Neurol Sci; 2006 Apr; 243(1-2):83-6. PubMed ID: 16445943
[TBL] [Abstract][Full Text] [Related]
11. [Cerebrotendinous xanthomatosis, a treatable metabolic disorder].
Heller R; Grau AJ; Schäbitz WR; Schwaninger M
Nervenarzt; 2002 Dec; 73(12):1160-6. PubMed ID: 12486565
[TBL] [Abstract][Full Text] [Related]
12. Increased concentrations of cholestanol and apolipoprotein B in the cerebrospinal fluid of patients with cerebrotendinous xanthomatosis. Effect of chenodeoxycholic acid.
Salen G; Berginer V; Shore V; Horak I; Horak E; Tint GS; Shefer S
N Engl J Med; 1987 May; 316(20):1233-8. PubMed ID: 3106810
[TBL] [Abstract][Full Text] [Related]
13. Long-term follow-up on the effect of combined therapy of bile acids and statins in the treatment of cerebrotendinous xanthomatosis: a case report.
Luyckx E; Eyskens F; Simons A; Beckx K; Van West D; Dhar M
Clin Neurol Neurosurg; 2014 Mar; 118():9-11. PubMed ID: 24529221
[No Abstract] [Full Text] [Related]
14. [Cerebrotendinous xanthomatosis: a multicentric retrospective study of 15 adults, clinical and paraclinical typical and atypical aspects].
Lionnet C; Carra C; Ayrignac X; Levade T; Gayraud D; Castelnovo G; Besson G; Androdias G; Vukusic S; Confavreux C; Zaenker C; De Seze J; Collongues N; Blanc F; Tranchant C; Wallon D; Hannequin D; Gerdelat-Mas A; Brassat D; Clanet M; Zephir H; Outteryck O; Vermersch P; Labauge P
Rev Neurol (Paris); 2014; 170(6-7):445-53. PubMed ID: 24746394
[TBL] [Abstract][Full Text] [Related]
15. [Cerebrotendinous xanthomatosis: utility of nuclear magnetic resonance image in the follow-up and response to treatment].
Cuende E; Gómez-Rz de Mendarozqueta M; Vesga JC; Saracíbar N; Ibáñez-Avilés A; Castellano-Hurtado C
Rev Neurol; 1996 Dec; 24(136):1535-8. PubMed ID: 9064170
[TBL] [Abstract][Full Text] [Related]
16. Cerebrotendinous xanthomatosis: a rare cause of spinocerebellar syndrome.
Ostrowska M; Banaszkiewicz K; Kiławiec A; Róg T; Lütjohann D; Szczudlik A
Neurol Neurochir Pol; 2011; 45(6):600-603. PubMed ID: 22212991
[TBL] [Abstract][Full Text] [Related]
17. [Cerebrotendinous xanthomatosis: report of 4 patients].
Ferrándiz-Pulido C; Bartralot R; Girós M; Bassas P; Heras C; Bodet D; Savall R; García-Patos V
Actas Dermosifiliogr; 2009 Apr; 100(3):222-6. PubMed ID: 19457308
[TBL] [Abstract][Full Text] [Related]
18. Combined treatment with LDL-apheresis, chenodeoxycholic acid and HMG-CoA reductase inhibitor for cerebrotendinous xanthomatosis.
Ito S; Kuwabara S; Sakakibara R; Oki T; Arai H; Oda S; Hattori T
J Neurol Sci; 2003 Dec; 216(1):179-82. PubMed ID: 14607320
[TBL] [Abstract][Full Text] [Related]
19. [Cerebrotendinous xanthomatosis].
Berginer VM
Zh Nevropatol Psikhiatr Im S S Korsakova; 1992; 92(4):13-22. PubMed ID: 1333699
[TBL] [Abstract][Full Text] [Related]
20. [Cerebrotendinous xanthomatosis. 2 cases with magnetic resonance imaging].
Rogelet P; Gérard JM; Michotte A; Masingue M; Destée A
Rev Neurol (Paris); 1992; 148(8-9):541-5. PubMed ID: 1494725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
